NEUROGENIC DETRUSOR OVERACTIVITY
Clinical trials for NEUROGENIC DETRUSOR OVERACTIVITY explained in plain language.
Never miss a new study
Get alerted when new NEUROGENIC DETRUSOR OVERACTIVITY trials appear
Sign up with your email to follow new studies for NEUROGENIC DETRUSOR OVERACTIVITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Daily pill aims to improve bladder function in children with spinal conditions
Disease control Recruiting nowThis study tests a daily pill called vibegron to see if it safely improves bladder control in children aged 2 to 18 with neurogenic detrusor overactivity (NDO), a condition where the bladder contracts too often due to nerve damage. Participants must already use a catheter to empt…
Matched conditions: NEUROGENIC DETRUSOR OVERACTIVITY
Phase: PHASE2, PHASE3 • Sponsor: Urovant Sciences GmbH • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New injection aims to stop bladder leaks in spinal cord injury patients
Disease control Recruiting nowThis early study tests a single treatment of EG110A injections into the bladder muscle for adults with spinal cord injury who still have bladder leaks despite standard care. The goal is to see if the treatment is safe and can reduce incontinence. Sixteen participants will be foll…
Matched conditions: NEUROGENIC DETRUSOR OVERACTIVITY
Phase: PHASE1, PHASE2 • Sponsor: EG 427 • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC